Clinical trials
Phase 3 Colonic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 6 |
| NCIC Clinical Trials Group | 3 |
| Amgen | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| Sanofi | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| GlaxoSmithKline | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 31 |
| Colorectal Neoplasms | 22 |
| Rectal Neoplasms | 17 |
| Neoplasms | 4 |
| Colonic Diseases | 2 |
| Digestive System Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Gastrointestinal Diseases | 2 |
| Gastrointestinal Neoplasms | 2 |
| Intestinal Diseases | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.